ITabMed logo — company profile

ITabMed

Founded 2020 2 employees Series A Total: $20.00M Biopharma, Biotechnology +2

General Information

Company Name ITabMed
Founded Year 2020
Employees 2
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with ITabMed. To contact ITabMed, visit itabmed.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About ITabMed

ITabMed is a bio-pharmaceutical and biotechnology startup founded in 2020. The company operates within the biopharma, biotechnology, and health care industries. ITabMed recently secured a significant $20.00M Series A investment on 01 December 2021. The round was led by 3E Bioventures Capital, and also saw participation from Yongjin Group, Regent Capital, and Binhai Capital. This investment is set to further drive the growth and development of ITabMed as it continues to make strides in the biopharmaceutical and biotechnology sectors.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $20.00M 4
3E Bioventures Capital, Yongjin Group +2
01 Dec 2021

ITabMed Alternatives & Competitors

View All Alternatives
ITabMed vs

Harbin Pharma is a pharmaceuticals company based out of HAERBIN, HNG, China.

Post-IPO Equity
15 employees
Biotechnology, Health Care
ITabMed vs

上海健信生物医药科技有限公司 is a pharmaceuticals company based out of 上海, 上海, China.

Series B
6 employees
Biopharma, Biotechnology
ITabMed vs

上海博悦生物科技有限公司 is a pharmaceuticals company based out of 上海, 上海, China.

Corporate Round
13 employees
Biopharma, Biotechnology

FAQ About ITabMed

ITabMed is a company based out of China.
ITabMed was founded in 2020.
ITabMed operates in Biopharma, Biotechnology, Health Care and Health and Wellness.
ITabMed has approximately 2 employees.
ITabMed has completed 1 funding round, raising a total of $20.00M. The latest funding stage is Series A.
Top alternatives and competitors to ITabMed include Harbin Pharmaceutical Group Co., Ltd., 上海健信生物医药科技有限公司, 上海博悦生物科技有限公司, 微岩医学科技(北京)有限公司, 成都纽瑞特医疗科技股份有限公司. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ITabMed and Harbin Pharmaceutical Group Co., Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ITabMed, https://bouncewatch.com/company/itabmed, updated 1 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes